InsiderTrades.com logo
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

RAT Insider Trading

Insider Ownership Percentage: 38.62%
Insider Buying (Last 12 Months): £44,387.64
Insider Selling (Last 12 Months): GBX 0

Rathbones Group Insider Trading History Chart

This chart shows the insider buying and selling history at Rathbones Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rathbones Group Share Price & Price History

Current Price: GBX 1,600
Price Change: ▼ Price Decrease of -22 (-1.36%)
As of 04/25/2024 01:00 AM ET

This chart shows the closing price history over time for RAT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

Rathbones Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/4/2024Paul StocktonInsiderBuy9GBX 1,556£140.04
3/4/2024Paul StocktonInsiderBuy10GBX 1,580£158
2/5/2024Paul StocktonInsiderBuy9GBX 1,610£144.90
1/4/2024Paul StocktonInsiderBuy9GBX 1,704£153.36
12/4/2023Paul StocktonInsiderBuy9GBX 1,608£144.72
11/6/2023Jennifer MathiasInsiderBuy10GBX 1,574£157.40
9/4/2023Paul StocktonInsiderBuy9GBX 1,736£156.24
8/29/2023Iain CummingsInsiderBuy42GBX 1,697£712.74
8/4/2023Paul StocktonInsiderBuy9GBX 1,710£153.90
7/4/2023Jennifer MathiasInsiderBuy8GBX 1,894£151.52
5/18/2023Iain CummingsInsiderBuy1,158GBX 1,955£22,638.90
5/4/2023Sarah GentlemanInsiderBuy1,028GBX 1,914£19,675.92
8/4/2022Paul StocktonInsiderBuy8GBX 1,852£148.16
5/11/2022Iain CummingsInsiderBuy33GBX 2,009£662.97
12/2/2021Iain CummingsInsiderBuy1,250GBX 1,898£23,725
11/4/2021Paul StocktonInsiderBuy8GBX 1,970£157.60
10/14/2021Dharmash MistryInsiderBuy2,500GBX 1,943£48,575
9/6/2021Paul StocktonInsiderBuy7GBX 2,055£143.85
8/4/2021Paul StocktonInsiderBuy8GBX 1,908£152.64
7/5/2021Paul StocktonInsiderBuy8GBX 1,860£148.80
6/4/2021Paul StocktonInsiderBuy8GBX 1,858£148.64
See Full Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for Rathbones Group (LON:RAT)

52.98% of Rathbones Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Rathbones Group logo
Rathbones Group Plc, together with its subsidiaries, provides individual wealth management, asset management, and related services for private clients, charities, trustees, and professional partners in the United Kingdom, Channel Island, and internationally. The company operates through two segments, Wealth Management and Asset Management. Its services include discretionary investment management, asset management, financial planning and advisory, and international investment services, as well as trust and tax services. The company was formerly known as Rathbone Brothers Plc and changed its name to Rathbones Group Plc in December 2021. Rathbones Group Plc was founded in 1742 and is headquartered in London, the United Kingdom.
Read More on Rathbones Group

Today's Range

Now: GBX 1,600
Low: 1,600
High: 1,634

50 Day Range

MA: GBX 1,555.28
Low: 1,494
High: 1,624

52 Week Range

Now: GBX 1,600
Low: 1,436
High: 2,050

Volume

51,915 shs

Average Volume

77,385 shs

Market Capitalization

£1.45 billion

P/E Ratio

3,137.25

Dividend Yield

5.36%

Beta

0.68

Who are the company insiders with the largest holdings of Rathbones Group?

Rathbones Group's top insider investors include:
  1. Iain Cummings (Insider)
  2. Jennifer Mathias (Insider)
  3. Paul Stockton (Insider)
  4. Sarah Gentleman (Insider)
Learn More about top insider investors at Rathbones Group.
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...